Stay informed with the latest litigation news. Explore now

IP Verse

Merck Sharp & Dohme competitive analysis

Latest publications and patents of Merck Sharp & Dohme New

Explore the latest publications and patents granted to Merck Sharp & Dohme, showcasing their recent innovations and technological advancements.

Last updated on: Sep 7, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Merck Sharp & Dohme

EP4601694
Aug 20, 2025Compositions And Methods For Treating Cancer With Subcutaneous Administration Of Anti-Pd1 AntibodiesPending
EP4601693
Aug 20, 2025Compositions And Methods For Treating Cancer With Subcutaneous Administration Of Anti-Pd1 AntibodiesPending
EP4373849
Aug 20, 2025Il-2 Muteins For Treating Cancer Or InfectionPending
EP4594743
Aug 6, 2025An Analytical Method Using Lc-Ms/Ms Proteomics To Characterize Proteins Translated From MrnaPending
EP4426378
Aug 6, 2025Multi-Cartridge Injector And Methods Of Making And Using SamePending
EP4426257
Aug 6, 2025Vial-To-Syringe Converter And Methods Of Making And Using SamePending
EP3794599
Aug 6, 2025Cut Vertex Method For Identifying Complex Molecule SubstructuresGranted
EP3794597
Aug 6, 2025Complex Molecule Substructure Identification Systems, Apparatuses And MethodsGranted
EP4419110
Jul 30, 2025Treatment Of Viruses With Antiviral NucleosidesPending
EP4308695
Jul 30, 2025A Closed-System Upstream Manufacturing Process For Dengue Virus ProductionPending

Latest oppositions filed by Merck Sharp & Dohme

Explore patent oppositions filed by Merck Sharp & Dohme against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP4241767
Novel Lipids And Compositions For The Delivery Of TherapeuticsARBUTUS BIOPHARMAJul 23, 2025
EP3597659
Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECHDec 1, 2023
EP3597216
Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses ThereofE R SQUIBB & SONSApr 27, 2023
EP3760715
Large-Scale Production Of Soluble HyaluronidaseHALOZYMEMay 4, 2022
EP2863895
Tablet Formulation Comprising A Peptide And A Delivery AgentNOVO NORDISKJan 13, 2022
EP3322731
Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBBOct 12, 2021
EP3096785
Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens And Uses ThereofPFIZERJun 4, 2021
EP2382228
Compositions And Methods Of Treating Inflammatory And Autoimmune DiseasesAMGENMay 26, 2021
EP3002298
Anti-Factor Xi Monoclonal Antibodies And Methods Of Use ThereofOREGON HEALTH & SCIENCE UNIVERSITYApr 8, 2020
EP3326641
Rna Containing Composition For Treatment Of Tumor DiseasesCUREVACMar 24, 2020

Latest patents of Merck Sharp & Dohme opposed by its competitors

Explore Merck Sharp & Dohme's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3165220
Nov 13, 2024Pharmaceutical Composition Containing An Anti-Nucleating Agent2
EP3616695
Oct 23, 2024Methods For Treating Intrapulmonary Infections1
EP3283882
Oct 16, 2024Blood-Based Biomarkers Of Tumor Sensitivity To Pd-1 Antagonists1
EP3678654
Jun 26, 2024Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein Conjugates3
EP1841493
May 29, 2024Applicator For Inserting An Implant1
EP3417905
Sep 13, 2023Applicator For Inserting An Implant1
EP3265122
May 4, 2022Combination Of A Pd-1 Antagonist And Eribulin For Treating Cancer4
EP2981821
Nov 3, 2021Immunohistochemical Assay For Detecting Expression Of Programmed Death Ligand 1 (Pd-L1) In Tumor Tissue1
EP2931301
Sep 15, 2021Process For Purifying Insulin And Analogues Thereof1
EP3498734
Sep 1, 2021Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer7

Latest PTAB cases involving Merck Sharp & Dohme New

Discover the latest PTAB cases involving Merck Sharp & Dohme, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 13, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Merck Sharp & Dohme

PGR2025-00052Jun 27, 2025MERCK SHARP & DOHMEHALOZYMEPreliminary response waived
PGR2025-00053Jun 6, 2025MERCK SHARP & DOHMEHALOZYMEPreliminary response waived
PGR2025-00050May 7, 2025MERCK SHARP & DOHMEHALOZYMEPreliminary response waived
PGR2025-00046Apr 29, 2025MERCK SHARP & DOHMEHALOZYMEPreliminary response waived
PGR2025-00042Apr 15, 2025MERCK SHARP & DOHMEHALOZYMEPreliminary response waived
PGR2025-00039Mar 28, 2025MERCK SHARP & DOHMEHALOZYMEPending
PGR2025-00033Mar 7, 2025MERCK SHARP & DOHMEHALOZYMEPending
PGR2025-00024Feb 21, 2025MERCK SHARP & DOHMEHALOZYMEPending
PGR2025-00030Feb 4, 2025MERCK SHARP & DOHMEHALOZYMEPending
PGR2025-00017Jan 17, 2025MERCK SHARP & DOHMEHALOZYMETrial Instituted

Top competitors of Merck Sharp & Dohme

Top competitors of Merck Sharp & Dohme based on patent oppositions.